Mller cell gliosis, marked by an increase in glial fibrillary acidic protein (GFAP), can cause excitotoxicity-induced cell death of RGCs [92]
Publishers note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Further reading and references Wilding et al: Once-Weekly Semaglutide in Adults with Overweight or Obesity Moiz et al: Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes Rubino et al: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial Bolek et al: Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity About the authorView full bio Dr Nienke Lees Women's Health Service Lead MB BChir, MA, MRCS(ENT), DOHNS, MRCGP, LMCA Dr Nienke Lees is the Women's Health Service Lead at Genwell
And maintaining consistent injection timing and injection site rotation helps maintain stable blood levels during the adjustment period
$100 Special Promotions & Discounts Check out our latest deals and offers
A 2023 analysis of the FDA Adverse Event Reporting System (FAERS) identified increased reporting of gastroparesis among GLP-1 users compared to other diabetes medications